» Articles » PMID: 21885626

Telomere Dysfunction Causes Sustained Inflammation in Chronic Obstructive Pulmonary Disease

Abstract

Rationale: Chronic obstructive pulmonary disease (COPD) is associated with chronic inflammation of unknown pathogenesis.

Objectives: To investigate whether telomere dysfunction and senescence of pulmonary vascular endothelial cells (P-ECs) induce inflammation in COPD.

Methods: Prospective comparison of patients with COPD and age- and sex-matched control smokers. Investigation of mice null for telomerase reverse transcriptase (Tert) or telomerase RNA component (Terc) genes.

Measurements And Main Results: In situ lung specimen studies showed a higher percentage of senescent P-ECs stained for p16 and p21 in patients with COPD than in control subjects. Cultured P-ECs from patients with COPD exhibited early replicative senescence, with decreased cell-population doublings, a higher percentage of β-galactosidase-positive cells, reduced telomerase activity, shorter telomeres, and higher p16 and p21 mRNA levels at an early cell passage compared with control subjects. Senescent P-ECs released cytokines and mediators: the levels of IL-6, IL-8, monocyte chemotactic protein (MCP)-1, Hu-GRO, and soluble intercellular adhesion molecule (sICAM)-1 were elevated in the media of P-ECs from patients compared with control subjects at an early cell passage, in proportion to the senescent P-EC increase and telomere shortening. Up-regulation of MCP-1 and sICAM-1 led to increased monocyte adherence and migration. The elevated MCP-1, IL-8, Hu-GROα, and ICAM-1 levels measured in lungs from patients compared with control subjects correlated with P-EC senescence criteria and telomere length. In Tert(-/-) and/or Terc(-/-) mouse lungs, levels of the corresponding cytokines (MCP-1, IL-8, Hu-GROα, and ICAM-1) were also altered, despite the absence of external stimuli and in proportion to telomere dysfunction.

Conclusions: Telomere dysfunction and premature P-EC senescence are major processes perpetuating lung inflammation in COPD.

Citing Articles

Modeling the Aging Human Lung: Generation of a Senescent Human Lung Organoid Culture System.

Aspal M, Pushlar N, Melameka M, McVicar R, Smith E, Ogunyamoju T bioRxiv. 2025; .

PMID: 40060424 PMC: 11888323. DOI: 10.1101/2025.02.24.639173.


Endothelial dysfunction in chronic obstructive pulmonary disease: an update on mechanisms, assessment tools and treatment strategies.

Marcuccio G, Candia C, Maniscalco M, Ambrosino P Front Med (Lausanne). 2025; 12:1550716.

PMID: 40046916 PMC: 11880998. DOI: 10.3389/fmed.2025.1550716.


Research advances in polyphenols from Chinese herbal medicine for the prevention and treatment of chronic obstructive pulmonary disease: a review.

Zhang Y, Wang L, Zeng J, Shen W Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40035820 DOI: 10.1007/s00210-025-03945-y.


Genetic Risk Factors in Idiopathic and Non-Idiopathic Interstitial Lung Disease: Similarities and Differences.

Cerri S, Manzini E, Nori O, Pacchetti L, Rossi L, Turchiano M Medicina (Kaunas). 2025; 60(12.

PMID: 39768847 PMC: 11677115. DOI: 10.3390/medicina60121967.


Hyperbaric oxygen therapy as a neuromodulatory technique: a review of the recent evidence.

Bin-Alamer O, Abou-Al-Shaar H, Efrati S, Hadanny A, Beckman R, Elamir M Front Neurol. 2024; 15:1450134.

PMID: 39445195 PMC: 11496187. DOI: 10.3389/fneur.2024.1450134.